Fish Vaccines: Market Insights
Vaccination plays a vital role in large scale fish farming production. Vaccination of fish provides protection against common viral or bacterial diseases. Fish vaccines can radially reduce the mortality rate and increase the production rate. Fish vaccines is the best method to enhance the survival rate and increase the profitability of the aquaculture business. Fish vaccines is generally given to species such as Salmon, Sea Bass and Cod. Fish vaccines is widely used method in aquaculture. Fish vaccines market has excellent growth opportunities globally. According to the Food and Agriculture Organization of the United Nations, in 2016, global production of fish is estimated to be 171 million tones with aquaculture representing 47% of the total and 53% if non-food uses. With increase in production of fish, fish vaccines market register significant growth in coming years.
Download sample copy of this report:
Fish Vaccines: Market Dynamics
Fish vaccines exhibit exponential growth in the market owing to increasing survival rate and high production of fish in large scale commercial production of fish. In addition to this, fish vaccines is cost effective and provide long lasting prophylactic effect in the fish which as a result enhance high immunity and greater production of fish. Apart from this, with growing number of aquaculture sectors, the fish vaccines will spur the growth of the market. However, there are certain limitation in fish vaccines. Production of cost effective antigens and adjuvants bearing hurdles related to environment and regulatory concerns faced by manufacturers may impact the fish vaccines market. Apart from this, need for sophisticated skilled workforce in injecting the vaccination and significant handling problem and risk associated with fungal infections will overall hinder the growth of the market
Fish Vaccines Market: Overview
Fish vaccines register considerable growth in the market owing to rising aquaculture farms and rapid development in launch of new vaccines in the market. Apart from this, advancement in technology and development of novel adjuvants has led to increase in growth of the fish vaccines market. Some of the future aspects of fish vaccines may include marker vaccines, novel expression systems, passive immunization, immunostimulants, improved DNA vaccines and adjuvants will likely to spur the growth of the fish vaccines market. So far, most of the commercially available vaccines are inactivated. Injectable vaccines containing adjuvants is widely used for fish vaccines. Continuous effort has been made in minimizing the consumptions of antibiotics and provide a sustain biological production.
Buy Now to Get 10% Off and Free Customization as per Requirement:
Fish Vaccines: Region-wise Outlook
On the basis of geography, the global prophylactic HIV drugs market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, and Asia Pacific excluding Japan and Middle East & Africa. North America is projected to hold the significant share in the fish vaccines market due to growing aquaculture industry in the region and increase in research and development in bringing out novel adjuvants for fish vaccines. Europe register considerable growth in the fish vaccines market owing to large production of fish in the region and growing number of aquaculture farms. Asia Pacific also has tremendous potential in fish vaccines market due to rising economy and population growth and high consumption of fish in the region has led to increase in growth of the market. Middle East and Africa has comparatively low growth in fish vaccines market owing to lack of skilled workforce in fish vaccination and low supply of veterinary vaccines may impact the growth of the market.
Fish Vaccines Market: Key Players
Some of the key players present across the value chain of the global fish vaccines market are Lumic A/S, Syndel USA, PHARMAQ, CZ Vaccines, Marrinovak Ltd, MSD Animal Health, Anicon Labor GmbH.